BPCR BioPharma Credit PLC
0.9680USD-1.22%Mkt Cap: 1.10B $P/E: 9.80Today
Industry Peers
Asset Management$173.79BUSDP/E 25.6
$133.67BUSDP/E 25.0
INVE-B
Investor AB (publ)$119.41BUSDP/E 4.8
INVE-A
Investor AB (publ)$117.07BUSDP/E 4.7
$82.82BUSDP/E 28.6
$85.69BUSDP/E 70.3
$82.55BUSDP/E 67.2
$73.88BUSDP/E 26.4
$71.08BUSDP/E 25.3
$68.24BUSDP/E 41.4
$47.85BUSDP/E 15.4
$43.37BUSDP/E 11.8
$38.40BUSDP/E 53.3
$33.31BUSDP/E 28.7
$30.77BUSDP/E 14.5
$30.25BUSDP/E 13.7
$26.41BUSDP/E 4.4
$24.90BUSD
$23.46BUSD
$23.28BUSDP/E 15.5
| Headline | Source | Time |
|---|---|---|
This week | ||
SSimply Wall Street | ||
Older | ||
 What BioPharma Credit (BPCP) Said on Its H1 Earnings Call BioPharma Credit (LON:BPCP) reported a higher share price and continued portfolio diversification in its half-year investor presentation, while manager Pharmakon said it is managing cash to support new lending opportunities and potential future repayments. Pedro Gonzalez de Cosio, chief executive o | ||
KKalkine | ||